Literature DB >> 26106233

Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin.

Paola Lucidi1, Francesca Porcellati1, Hannele Yki-Järvinen2, Matthew C Riddle3, Paola Candeloro1, Anna Marinelli Andreoli1, Geremia B Bolli4, Carmine G Fanelli1.   

Abstract

Entities:  

Year:  2015        PMID： 26106233     DOI： 10.2337/dc14-2662

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  2 in total

1.  Molecular Modeling and Bioinformatics Analysis of Drug-Receptor Interactions in the System Formed by Glargine, Its Metabolite M1, the Insulin Receptor, and the IGF1 Receptor.

Authors:  Margarita González-Beltrán; Claudio Gómez-Alegría
Journal:  Bioinform Biol Insights       Date:  2021-09-23

2.  Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs.

Authors:  Ulrich Werner; Norbert Tennagels; Carmine G Fanelli; Geremia B Bolli
Journal:  Diabetes Obes Metab       Date:  2020-10-19       Impact factor: 6.577
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.